IC
LRMR icon

IEQ Capital’s Larimar Therapeutics LRMR Stock Holding History

IEQ Capital’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$620K Buy
203,363
+89,325
+78% +$355K ﹤0.01% 1309
2026
Q1 		$513K Buy
114,038
+64,888
+132% +$259K ﹤0.01% 1293
2025
Q4 		$187K Sell
49,150
-15,713
-24% -$61.1K ﹤0.01% 1705
2025
Q3 		$210K Buy
64,863
+7,602
+13% +$28.5K ﹤0.01% 1673
2025
Q2 		$165K Buy
57,261
+40,801
+248% +$94.5K ﹤0.01% 1650
2025
Q1 		$35.4K Buy
+16,460
New +$52K ﹤0.01% 1570

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

IEQ Capital's LRMR Position: Q2 2026 in Review

IEQ Capital increased its Larimar Therapeutics (LRMR) stake by 78% in Q2 2026, buying an estimated $355K and bringing the position to 203,363 shares worth $620K. The position accounts for ﹤0.01% of the portfolio, ranked #1309.

IEQ Capital first reported a position in LRMR in Q1 2025 and has held it in 6 quarters since. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • IEQ Capital held 203,363 shares of Larimar Therapeutics worth $620K as of Q2 2026.
  • IEQ Capital bought 89,325 Larimar Therapeutics shares in Q2 2026, an estimated $355K.
  • Larimar Therapeutics made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1309 holding.
  • IEQ Capital first reported a position in Larimar Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.